Ocular vascular occlusive disorders: Natural history of visual outcome

Progress in Retinal and Eye Research

Volumn 41, Issue 1, 2014, Pages 1-25

  Hayreh, Sohan Singh ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Branch retinal vein occlusion; Central retinal artery occlusion; Central retinal vein occlusion; Non arteritic anterior ischemic optic neuropathy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ADULT; AMBLYOPIA; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; BRANCH RETINAL ARTERY OCCLUSION; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CILIORETINAL ARTERY OCCLUSION; EARLY DIAGNOSIS; EPIRETINAL MEMBRANE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; ISCHEMIC OPTIC NEUROPATHY; MACULAR EDEMA; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PERFUSION PRESSURE; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA BLOOD FLOW; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; REVIEW; SMOKING; STEROID THERAPY; TRANSITIONAL BLINDNESS; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; YOUNG ADULT; OPTIC NEUROPATHY, ISCHEMIC; PATHOPHYSIOLOGY; REMISSION; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION;

HUMANS; OPTIC NEUROPATHY, ISCHEMIC; REMISSION, SPONTANEOUS; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; VISUAL ACUITY; VISUAL FIELDS;

EID: 84925545183     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2014.04.001     Document Type: Review

References (104)

1. Arnold A.C., Hepler R.S. Natural history of nonarteritic anterior ischemic optic neuropathy. J. Neuroophthalmol. 1994, 14:66-69.
2. Brown G.C., Magargal L.E. Central retinal artery obstruction and visual acuity. Ophthalmology 1982, 89:14-19.
3. Brown G.C., Moffat K., Cruess A., Magargal L.E., Goldberg R.E. Cilioretinal artery obstruction. Retina 1983, 3:182-187.
4. Chen J.C., Klein M.L., Watzke R.C., Handelman I.L., Robertson J.F. Natural course of perfused central retinal vein occlusion. Can. J. Ophthalmol. 1995, 30:21-24.
5. Chopdar A. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, natural history and incidence of dual trunk central retinal vein. Trans. Ophthalmol. Soc. U. K. 1982, 102:241-248.
6. Chopdar A. Dual trunk central retinal vein incidence in clinical practice. Arch. Ophthalmol. 1984, 102:85-87.
7. Chopdar A. Hemispheric retinal vein occlusion or hemicentral retinal vein occlusion. Arch. Ophthalmol. 1986, 104:1128-1130.
8. Clemett R.S., Kohner E.M., Hamilton A.M. The visual prognosis in retinal branch vein occlusion. Trans. Ophthalmol. Soc. U. K. 1973, 93:523-535.
9. David N., Norton E.W.D., Gass J.D., Beauchamp J. Fluorescein angiography in central retinal artery occlusion. Arch. Ophthalmol. 1967, 77:619-629.
10. Fineman M.S., Savino P.J., Federman J.L., Eagle R.C. Branch retinal artery occlusion as the initial sign of giant cell arteritis. Am. J. Ophthalmol. 1996, 122:428-430.
11. Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch. Ophthalmol. 1992, 110:1427-1434.
12. Fong A.C., Schatz H., McDonald H.R., Burton T.C., Maberley A.L., Joffe L., Zegarra H., Nadel A.J., Johnson R.N. Central retinal vein occlusion in young adults (papillophlebitis). Retina 1992, 12:3-11.
13. Garcia-Arumi J., Boixadera A., Martinez-Castillo V., Castillo R., Dou A., Corcostegui B. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch. Ophthalmol. 2003, 121:1385-1391.
14. Garcia-Arumi J., Martinez-Castillo V., Boixadera A., Fonollosa A., Corcostegui B. Surgical embolus removal in retinal artery occlusion. Br. J. Ophthalmol. 2006, 90:1252-1255.
15. Giuffré G., Palumbo C., Randazzo-Papa G. Optociliary veins and central retinal vein occlusion. Br. J. Ophthalmol. 1993, 77:774-777.
16. Giuffré G., Randazzo-Papa G., Palumbo C. Central retinal vein occlusion in young people. Doc. Ophthalmol. 1992, 80:127-132.
17. Glacet-Bernard A., Coscas G., Chabanel A., Zourdani A., Lelong F., Samama M.M. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 1996, 103:551-560.
18. Gómez-Ulla de Irazazabal F.J., Cadarso Suarez L., Orduña, Domingo E. Hemispheric retinal branch vein occlusions. Ophthalmologica 1986, 193:14-22.
19. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central vein occlusion: a prospective histological study of 29 eyes in 28 cases. Trans. Am. Ophthalmol. Soc. 1981, 79:371-421.
20. Hayreh S.S. Astudy of the central artery of the retina in human beings 1958, (Thesis for the Master of Surgery), Panjab University, India.
21. Hayreh S.S. The cilio-retinal arteries. Br. J. Ophthalmol. 1963, 47:71-89.
22. Hayreh S.S. Occlusion of the central retinal vessels. Br. J. Ophthalmol. 1965, 49:626-645.
23. Hayreh S.S. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br. J. Ophthalmol. 1969, 53:72l-748.
24. Hayreh S.S. Pathogenesis of visual field defects - role of the ciliary circulation. Br. J. Ophthalmol. 1970, 54:289-311.
25. Hayreh S.S. Pathogenesis of occlusion of the central retinal vessels. Am. J. Ophthalmol. 1971, 72:998-1011.
26. Hayreh S.S. Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br. J. Ophthalmol. 1974, 58:964-980.
27. Hayreh S.S. Central retinal vascular occlusion: morphology and pathogenesis. Ocular Angiology 1974, 15-40. Centro Minerva Medica, Rome. R. Brancato, F. Pratesi (Eds.).
28. Hayreh S.S. So-called "central retinal vein occlusion": 1. Pathogenesis, terminology, clinical features. Ophthalmologica 1976, 172:1-13.
29. Hayreh S.S. Anterior ischemic optic neuropathy. Arch Neurol. 1981, 38:675-678.
30. Hayreh S.S. Classification of central retinal vein occlusion. Ophthalmology 1983, 90:458-474.
31. Hayreh S.S. Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 1990, 4:25-41.
32. Hayreh S.S. Central retinal vein occlusion. Ophthalmol. Clin. North Am. 1998, 11:559-590.
33. Hayreh S.S. Retinal arterial occlusion with LIF using rTPA. Ophthalmology 1999, 106:1236-1238. 2044.
34. Hayreh S.S. Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management. Eye 2004, 18:1188-1206.
35. Hayreh S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog. Retin. Eye Res. 2005, 24:493-519.
36. Hayreh S.S. Surgical embolus removal in retinal artery occlusion. Br. J. Ophthalmol. 2007, 91:1096-1097.
37. Hayreh S.S. Restoration of retinal blood flow via translumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina 2008, 28:1369-1372.
38. Hayreh S.S. Ischemic optic neuropathy. Prog Retin Eye Res. 2009, 28:34-62.
39. Hayreh S.S. Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids?. J. Neuroophthamol. 2012, 32:278-287.
40. Hayreh S.S., Baines J.A.B. Occlusion of the posterior ciliary artery II. Chorio-retinal lesions. Br. J. Ophthalmol. 1972, 56:736-753.
41. Hayreh S.S., Baines J.A.B. Occlusion of the posterior ciliary artery III. Effects on the optic nerve head. Br. J. Ophthalmol. 1972, 56:754-764.
42. Hayreh S.S., Chopdar A. Occlusion of the posterior ciliary artery V. Protective influence of simultaneous vortex vein occlusion. Arch. Ophthalmol. 1982, 100:1481-1491.
43. Hayreh S.S., Fraterrigo L., Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion. Retina 2008, 28:581-594.
44. Hayreh S.S., Hayreh M.S. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history. Arch. Ophthalmol. 1980, 98:1600-1609.
45. Hayreh S.S., Jonas J.B. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. Am. J. Ophthalmol. 2000, 129:786-795.
46. Hayreh S.S., Joos K.M., Podhajsky P.A., Long C.R. Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am. J. Ophthalmol. 1994, 118:766-780.
47. Hayreh S.S., Klugman M.R., Beri M., Kimura A.E., Podhajsky P. Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch. Clin. Exp. Ophthalmol. 1990, 228:201-217.
48. Hayreh S.S., Kolder H.E., Weingeist T.A. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980, 87:75-78.
49. Hayreh S.S., Podhajsky P. Ocular neovascularization with retinal vascular occlusion II. Occurrence in central and branch retinal artery occlusion. Arch. Ophthalmol. 1982, 100:1585-1596.
50. Hayreh S.S., Podhajsky P.A., Zimmerman B. Ocular manifestations of giant cell arteritis. Am. J. Ophthalmol. 1998, 125:509-520.
51. Hayreh S.S., Podhajsky P.A., Zimmerman M.B. Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology 2009, 116:1188-1194.
52. Hayreh S.S., Podhajsky P.A., Zimmerman M.B. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011, 118:119-133.
53. Hayreh S.S., Podhajsky P.A., Zimmerman M.B. Central and hemi-central retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulant. Ophthalmology 2011, 118:1603-1611.
54. Hayreh S.S., Rojas P., Podhajsky P., Montague P., Woolson R.F. Ocular neovascularization with retinal vascular occlusion III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983, 90:488-506.
55. Hayreh S.S., van Heuven W.A.J., Hayreh M.S. Experimental retinal vascular occlusion I. Pathogenesis of central retinal vein occlusion. Arch. Ophthalmol. 1978, 96:311-323.
56. Hayreh S.S., Weingeist T.A. Experimental occlusion of the central artery of the retina l. Ophthalmoscopic and fluorescein fundus angiographic studies. Br. J. Ophthalmol. 1980, 64:896-912.
57. Hayreh S.S., Weingeist T.A. Experimental occlusion of the central artery of the retina IV. Retinal tolerance time to acute ischaemia. Br. J. Ophthalmol. 1980, 64:818-825. (See corrected bibliography and text corrections published in Br. J. Ophthalmol. 1981).
58. Hayreh S.S., Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003, 110:1204-1215.
59. Hayreh S.S., Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 2003, 217:239-259.
60. Hayreh S.S., Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial presentation. Arch. Ophthalmol. 2005, 123:1554-1562.
61. Hayreh S.S., Zimmerman B. Central retinal artery occlusion: visual outcome. Am. J. Ophthalmol. 2005, 140:376-391.
62. Hayreh S.S., Zimmerman M.B. Fundus changes in central retinal artery occlusion. Retina 2007, 27:276-289.
63. Hayreh S.S., Zimmerman M.B. Non-arteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008, 115:298-305.
64. Hayreh S.S., Zimmerman M.B. Hemi-central retinal vein occlusion: natural history of visual outcome. Retina 2012, 32:68-76.
65. Hayreh S.S., Zimmerman M.B. Ocular neovascularization associated with central and hemi-central retinal vein occlusion. Retina 2012, 32:1553-1565.
66. Hayreh S.S., Zimmerman M.B. Branch retinal vein occlusion: natural history of visual outcome. JAMA Ophthalmol. 2014, 132:3-22.
67. Hayreh S.S., Zimmerman M.B. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses. Retina 2014, 34:115-122.
68. Hayreh S.S., Zimmerman B., Kardon R.H. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol. Scand. 2002, 80:355-367.
69. Hayreh S.S., Zimmerman M.B., Kimura A., Sanon A. Central retinal artery occlusion. Retinal survival time. Exp. Eye Res. 2004, 78:723-736.
70. Hayreh S.S., Zimmerman M.B., Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am. J. Ophthalmol. 1994, 117:429-441.
71. Heier J.S., Clark W.L., Boyer D.S., Brown D.M., Vitti R., Berliner A.J., Kazmi H., Ma Y., Stemper B., Zeitz O., Sandbrink R., Haller J.A. Intravitreal Aflibercept injection for macular edema due to Central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology Mar 26 2014, pii: S0161-6420. (Epub ahead of print).
72. Ischemic Optic Neuropathy Decompression Trial Research Group Ischemic optic neuropathy decompression trial: twenty-four-month update. Arch. Ophthalmol. 2000, 118:793-797.
73. Ischemic Optic Neuropathy Decompression Trial Research Group Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. J. Am. Med. Assoc. 1995, 273:625-632.
74. Juarez C.P., Tso M.O.M., van Heuven W.A.J., Hayreh M.S., Hayreh S.S. Experimental retinal vascular occlusion II. A clinico-pathologic correlative study of simultaneous occlusion of central retinal vein and artery. Int. Ophthalmol. 1986, 9:77-87.
75. Juarez C.P., Tso M.O.M., van Heuven W.A.J., Hayreh M.S., Hayreh S.S. Experimental retinal vascular occlusion III. An ultrastructural study of simultaneous occlusion of central retinal vein and artery. Int. Ophthalmol. 1986, 9:89-101.
76. Kwon Y.H., Rickman D.W., Baruah S., Zimmerman M.B., Kim C.-S., Boldt H.C., Russell S.R., Hayreh S.S. Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate. Eye 2005, 9:455-463.
77. Mann I. The Development of the Eye 1969, 228. Grune & Stratton Inc., New York.
78. Mason J.O., Nixon P.A., Albert M.A. Trans-luminal nd: YAG laser embolysis for branch retinal artery occlusion. Retina 2007, 27:573-577.
79. Mason J.O., Shah A.A., Vail R.S., Nixon P.A., Ready E.L., Kimble J.A. Branch retinal artery occlusion: visual prognosis. Am. J. Ophthalmol. 2008, 46:455-457.
80. Michel J. Ueber die anatomischen Ursachen von Veranderungen des Augenhintergrundes bei einigen Allgemeinerkrankungen. Dtsch. Arch. Klin. Med. 1878, 22:339-345.
81. Mizener J.B., Podhajsky P., Hayreh S.S. Ocular ischemic syndrome. Ophthalmology 1997, 104:859-864.
82. Moore R.F. Retinal venous thrombosis. A clinical study of sixty-two cases followed over many years. Br. J. Ophthalmol. 1924, 2(Suppl.):4.
83. Oeller J. Atlas der Ophtlzaimoscopie Wiesbaden. C. Tabs XIII 1896-1899.
84. Opremcak E., Rehmar A.J., Ridenour C.D., Borkowski L.M., Kelley J.K. Restoration of retinal blood flow via traslumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina 2008, 28:226-235.
85. Parodi M.B., Moretti G., Ravalico G. Hemicentral and hemispheric retinal vein occlusions. Metab. Pediatr. Syst. Ophthalmol. 1992, 15:64-67.
86. Petrig B.L., Riva C.E., Hayreh S.S. Laser Doppler flowmetry and optic nerve head blood flow. Am. J. Ophthalmol. 1999, 127:413-425.
87. Priluck I.A., Robertson D.M., Hollenhorst R.W. Long-term follow-up of occlusion of the central retinal vein in young adults. Am. J. Ophthalmol. 1980, 90:190-202.
88. Quinlan P.M., Elman M.J., Bhatt A.K., Mardesich P., Enger C. The natural course of central retinal vein occlusion. Am. J. Ophthalmol. 1990, 110:118-123.
89. Repka M.X., Savino P.J., Schatz N.J., Sergott R.C. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am. J. Ophthalmol. 1983, 96:478-483.
90. Richard G., Lerche R.C., Knospe V., Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 1999, 106:768-773.
91. Rogers S.L., McIntosh R.L., Lim L., Mitchell P., Cheung N., Kowalski J.W., Nguyen H.P., Wang J.J., Wong T.Y. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010, 117:1094-1101.
92. Sanborn G.E., Magargal L.E. Characteristics of the hemispheric retinal vein occlusion. Ophthalmology 1984, 91:1616-1626.
93. Sawle G.V., James C.B., Russell R.W. The natural history of non-arteritic anterior ischaemic optic neuropathy. J. Neurol. Neurosurg. Psychiatry 1990, 53:830-833.
94. Sergott R.C., Cohen M.S., Bosley T.M., Savino P.J. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch. Ophthalmol. 1989, 107:1743-1754.
95. Singh (Hayreh) S., Dass R. The central artery of the retina I. Origin and course. Br. J. Ophthalmol. 1960, 44:193-212.
96. Singh (Hayreh) S., Dass R. The central artery of the retina II. Distribution and anastomoses. Br. J. Ophthalmol. 1960, 44:280-299.
97. The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am. J. Ophthalmol. 1984, 98:271-282.
98. The Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 1997, 115:486-491.
99. The SCORE Study Research Group Arandomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion. Arch. Ophthalmol. 2009, 127:1101-1114.
100. Varma R., Bressler N.M., Suñer I., Lee P., Dolan C.M., Ward J., Colman S., Rubio R.G., BRAVO and CRUISE Study Groups Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012, 119:2108-2118.
101. Von Graefe A. Über Embolie der Arteria centralis retinae als Ursache plötzlicher Erblindung. Graefes Arch. Ophthalmol. 1859, 5(1):136-185.
102. Watson P.G. The treatment of acute retinal arterial occlusion. The William MacKenzie Centenary Symposium on the Ocular Circulation in Health and Disease (1968, Glasgow) 1969, 234-245. Kimpton, London. J.S. Cant (Ed.).
103. Yuzurihara D., Iijima H. Visual outcome in central retinal and branch retinal artery occlusion. Jpn. J. Ophthalmol. 2004, 48:490-492.
104. Zegarra H., Gutman F.A., Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979, 86:1931-1942.